PedAM
Pediatric Disease Annotations & Medicines
| Disease | liver disease |
| Phenotype | C0019204|hepatocellular carcinoma |
| Sentences | 82 |
| PubMedID- 25785178 | Comparison of the accuracy of dwi and ultrasonography in screening hepatocellular carcinoma in patients with chronic liver disease. |
| PubMedID- 23091810 | We investigated whether apoe genotype determines the disease outcome in hepatitis b virus (hbv)-infected individuals, and verified the association between apoe genotype and the occurrence of hepatocellular carcinoma (hcc) in patients with chronic liver diseases of various etiologies. |
| PubMedID- 22116467 | Loss of retinoid-containing lipid droplets upon hepatic stellate cell (hsc) activation is one of the first events in the development of liver disease leading to hepatocellular carcinoma. |
| PubMedID- 22869157 | This study was conducted to determine whether pnpla3 rs738409 snps affect development and prognosis of hepatocellular carcinoma (hcc) in patients with various liver diseases. |
| PubMedID- 20818940 | Hepatitis c virus (hcv) infection spreads primarily via contact with infected blood and can establish a persistent infection in 80% of infected individuals, progressively causing chronic liver disease that can lead to hepatocellular carcinoma or end-stage liver disease requiring a transplant. |
| PubMedID- 20956466 | This prospective study aimed to compare the diagnostic performance of (18)f-fluorocholine and (18)f-fdg for detecting and staging hepatocellular carcinoma (hcc) in patients with chronic liver disease and suspected liver nodules. |
| PubMedID- 26523271 | Growth rate of early-stage hepatocellular carcinoma in patients with chronic liver disease. |
| PubMedID- 21920517 | hepatocellular carcinoma in patients with chronic liver disease: a comparison of gadoxetic acid-enhanced mri and multiphasic mdct. |
| PubMedID- 21874252 | Highly sensitive lens culinaris agglutinin-reactive alpha-fetoprotein is useful for early detection of hepatocellular carcinoma in patients with chronic liver disease. |
| PubMedID- 21688080 | Open liver resection for peripheral hepatocellular carcinoma in patients with chronic liver disease: a case-matched study. |
| PubMedID- 22576780 | Background: non-alcoholic fatty liver disease (nafld) can lead to cirrhosis and hepatocellular carcinoma and is strongly associated with obesity and insulin resistance. |
| PubMedID- 24073300 | Pure laparoscopic hepatectomy for hepatocellular carcinoma with chronic liver disease. |
| PubMedID- 23146507 | Background: liver transplantation (olt) represents the treatment of choice for small hepatocellular carcinomas (hcc) in patients with end-stage liver disease. |
| PubMedID- 24838304 | Imaging features of subcentimeter hypointense nodules on gadoxetic acid-enhanced hepatobiliary phase mr imaging that progress to hypervascular hepatocellular carcinoma in patients with chronic liver disease. |
| PubMedID- 25715363 | Objectives: to determine the usefulness of contrast-enhanced sonography using the perfluorobutane contrast agent sonazoid (daiichi-sankyo, tokyo, japan) for establishing the diagnosis and cellular differentiation of hepatocellular carcinoma in patients with chronic liver disease. |
| PubMedID- 24809655 | Questions remain about the relationship between type 2 diabetes mellitus (type 2 dm) and the risk of hepatocellular carcinoma (hcc), especially in patients with chronic liver diseases. |
| PubMedID- 22258434 | Risk factors for hepatocellular carcinoma in patients with chronic liver disease: a case-control study. |
| PubMedID- 22167508 | Small (hepatocellular carcinoma in patients with chronic liver disease: comparison of gadoxetic acid-enhanced 3.0 t mri and multiphasic 64-multirow detector ct. |
| PubMedID- 23903617 | Our aim was to characterize hepatocellular carcinoma according to etiology of the underlying chronic liver disease, and treatment modalities, in a referral center in brazil. |
| PubMedID- 21743215 | Hcv is a major cause of chronic liver disease that may lead to cirrhosis and hepatocellular carcinoma. |
| PubMedID- 25635247 | Hepatitis c virus (hcv) can cause chronic liver disease that ultimately leads to hepatocellular carcinoma (2). |
| PubMedID- 23905912 | Objectives: the incidence of hepatocellular carcinoma associated with nonalcoholic fatty liver disease is increasing. |
| PubMedID- 25744657 | Clinicopathological features of hepatocellular carcinoma in patients with nonalcoholic fatty liver disease. |
| PubMedID- 24058372 | The exclusion criteria included being coinfected with hav, hcv, hdv, hev, and hiv; hepatocellular carcinoma; other forms of liver disease; being other severe primary disease or mental disorder disease; treated to decrease the alt level within three months; and pregnant and lactating women. |
| PubMedID- 26327775 | Here we report the case of a patient with a large hepatocellular carcinoma arising from chronic liver disease. |
| PubMedID- 20592927 | For the detection of hepatocellular carcinoma (hcc) in patients with chronic liver disease, gadobenate dimeglumine-enhanced mri has demonstrated a higher sensitivity than has multidetector ct (mdct) for hccs (≤ 1 cm) (11) and gadobenate dimeglumine-enhanced mri has demonstrated a better diagnostic performance than ferucarbotran-enhanced mri (12). |
| PubMedID- 20589433 | Background: as is known for many types of human cancers, the hepatocellular carcinoma (hcc) associated with chronic liver disease shows an obvious multistage process of tumor progression. |
| PubMedID- 24361414 | Increased long-term survival among patients with hepatocellular carcinoma after implementation of model for end-stage liver disease score. |
| PubMedID- 21276439 | In this way the proinflammatory response, fibrogenesis, cirrhosis and hepatocellular carcinoma formation due to alcohol liver disease could be prevented by same. |
| PubMedID- 23190006 | Background and aim: the purpose of this study was to perform a meta-analysis of all available studies of the diagnostic performance of diffusion-weighted imaging (dwi) in the detection of hepatocellular carcinoma (hcc) in patients with chronic liver disease. |
| PubMedID- 26424404 | Consequently, the development of end-stage liver disease (esld) with cirrhosis and hepatocellular carcinoma occurs at a younger age in co-infected individuals [16]. |
| PubMedID- 21656309 | Risk factors influencing postoperative outcomes of major hepatic resection of hepatocellular carcinoma for patients with underlying liver diseases. |
| PubMedID- 21472122 | Obi might contribute to the progression of liver fibrosis and hepatocellular carcinoma development in patients with chronic liver disease. |
| PubMedID- 26234231 | hepatocellular carcinoma in a patient with polycystic liver disease. |
| PubMedID- 21970718 | After a sub-clinical phase, greater than 80% of patients progress to persistent hcv infection, the leading cause of chronic liver disease associated with cirrhosis and hepatocellular carcinoma [1,2]. |
| PubMedID- 21139506 | Conclusions: administration of double dose of gd-eob-dtpa provided better arterial enhancement of hepatocellular carcinomas in patients with chronic liver disease, and also improved the lesion-liver contrast in hepatocyte-phase images in patients with child-pugh class b disease. |
| PubMedID- 25276280 | Infection by the hcv can cause acute and chronic liver diseases and may lead to cirrhosis, hepatocellular carcinoma or liver failure. |
| PubMedID- 25065095 | Objective: to assess the benefit on diagnosis of hepatocellular carcinoma (hcc) in patients with chronic liver disease or cirrhosis with double contrast mr imaging compared to the routine gadolinium-based mr imaging. |
| PubMedID- 24927176 | Hepatitis c virus (hcv) infection causes chronic liver diseases leading to hepatocellular carcinoma (hcc) and liver failure. |
| PubMedID- 25387451 | This study examined whether glycated hemoglobin a1c (hba1c) and chronic liver diseases are associated with hepatocellular carcinoma (hcc) risk in type 2 diabetic patients. |
| PubMedID- 23884757 | Is liver-specific gadoxetic acid-enhanced magnetic resonance imaging a reliable tool for detection of hepatocellular carcinoma in patients with chronic liver disease. |
| PubMedID- 25103596 | Aims: to evaluate the value of spleen and liver apparent diffusion coefficients (adc) in chronic liver disease patients, with and without hepatocellular carcinoma (hcc), and to investigate the use of diffusion-weighted imaging (dwi) in the diagnosis and follow-up of hepatic fibrosis. |
| PubMedID- 22801423 | Hepatitis c virus (hcv) is the main agent of acute and chronic liver diseases leading to cirrhosis and hepatocellular carcinoma. |
| PubMedID- 22175908 | Aim: malignancies that include hepatocellular carcinoma often occurred in patients with chronic liver disease. |
| PubMedID- 24459650 | Hepatic abscess mimicking hepatocellular carcinoma in a patient with alcoholic liver disease. |
| PubMedID- 19760361 | Background: excellent survival obtained with liver transplantation (lt) for limited hepatocellular carcinoma (hcc) in patients with chronic liver disease is still challenged by the increasing discrepancy between candidates and grafts available. |
| PubMedID- 24112253 | Objective: to determine the frequency of development of hepatocellular carcinoma in patients with chronic liver disease secondary to hepatitis c who had achieved sustained virological response with interferon and ribavirin therapy. |
| PubMedID- 21418304 | Ubiquitin-proteasome profiling for enhanced detection of hepatocellular carcinoma in patients with chronic liver disease. |
| PubMedID- 20174556 | The hepatitis c virus (hcv) is a major cause of chronic liver disease worldwide, leading to cirrhosis and hepatocellular carcinoma [1]. |
| PubMedID- 23901347 | Several lines of evidence suggest that obi is associated with progression of liver fibrosis and the development of hepatocellular carcinoma in patients with chronic liver disease. |
Page: 1 2